Search for: "BM" Results 41 - 60 of 430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2014, 3:03 pm by Lawrence B. Ebert
Therefore, we see no error in the selection of 2′-CDGas the lead compound here. [read post]
9 Aug 2008, 1:40 am
The news surge of the week has obscured another huge increase in offshore oil reserves discovered by Brazil: Estimated Reserves ``Given the discovery, recoverable reserves on block BM-S- 11 could increase to 10... [read post]
21 Dec 2016, 2:45 pm by Juliet Preston - MedCity News
PsiOxus Therapeutics has signed a second agreement with Bristol-Myers Squibb (BMS), this time for worldwide rights to its ‘armed’ oncolytic virus NG-348, currently in the preclinical research phase. [read post]
20 Sep 2019, 10:16 am by Alaric Dearment - MedCity News
Nine senators sent a letter to FTC Chairman Joseph Simons urging greater scrutiny over like the one between BMS and Celgene, expressing concern over antitrust issues, innovation and drug pricing. [read post]
4 Oct 2007, 7:55 am
The first thing the government alleged was that from 2000 through 2003 BMS knowingly and willfully paid illegal renumeration to physicians and other healthcare providers to induce them to purchase BMS drugs. [read post]
15 Dec 2022, 5:00 pm
” Don Lee contended that BM exaggerated its products’ protein content and also misrepresented that it used no synthetic or artificial ingredients. [read post]
17 Oct 2018, 10:01 pm by Doug Austin
Jones denied the plaintiff’s Disclosure Motion regarding two documents that defendant Bristol-Myers Squibb (BMS) claimed were privileged and inadvertently disclosed, stating that “[a]lthough BMS might not have followed the precise terms of the Protective Order”, “the one-day delay in sending the privilege log can charitably be described as a...Read the whole entry... [read post]
15 Feb 2013, 9:29 am by Gregory J. Brodzik
Patent No. 5,206,244 (the “'244 Patent”) “in connection with BMS’s Baraclude Product,” and BMS sought to enforce claim 8 of that patent, which “covers the chemical compound entecavir. [read post]
23 Sep 2010, 9:43 pm by GenericIPguy
Justice Sunil Gaur of the Delhi Hight Court, on 24/Sep, declined an injunction against Ranbaxy in the BMS v. [read post]
21 Sep 2007, 9:17 pm
By Jason Derry -- Exelixis and Bristol-Myers Squibb have announced an agreement to extend their research collaboration relating to cardiovascular and metabolic diseases for an additional year, now ending in January 2009. [read post]
6 Mar 2022, 2:00 am by Katharine Van Tassel
Abdou Khadre Dit Jadir Fall (Université de Paris), Original or Generic Drugs: Mathematical Modelling of the Political Choice, SSRN (2022): The introduction of generic drugs has been strongly contended, especially in France where Sanofi and BMS-UPSA lobbied and obtained a... [read post]
30 Aug 2016, 5:45 am by Adam Steinman
From the introduction: Bristol Myers Squibb Company (BMS), a pharmaceutical manufacturer, conducts significant business... [read post]
29 Sep 2007, 9:21 pm
The United State Attorney for Massachusetts reports in a press release that "Bristol-Myers Squibb Company (BMS) and its wholly owned subsidiary, Apothecon, Inc., have agreed to pay in excess of $515 million to resolve a broad array of federal and... [read post]
19 Jun 2007, 9:45 pm
Sanofi and BMS filed the action in March of 2002, contending that... [read post]
10 Nov 2020, 9:58 am by Layla Flinn
To evaluate your corporation well, focus on their facilities both present and absent and then make an informed decision on the type of BMS you want to adopt. [read post]
6 Dec 2007, 9:43 am
"Elsewhere in the story BMS blaming loss of patent protection for Plavix in 2011. [read post]
19 Jun 2017, 12:51 pm by Adam Steinman
By an 8-1 vote, the Court reverses the California Supreme Court’s conclusion that asserting personal jurisdiction over Bristol-Myers Squibb (BMS) was... [read post]